Thoracoabdominal Aortic Aneurysms

Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Thoracoabdominal Aortic Aneurysm Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Diseases Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all adult consecutive patients presenting with TAAA larger than 5.5 cm

Exclusion criteria

active infection Asymptomatic patients with small aneurysms Allergy to contrast agents

Treatment and study plan

Fenestrated and branched endovascular devices for TAAA

Device

Devices for TAAA

Primary outcomes

Successful cannulation of the target vessels with complete in-line flow to target organs.

Time frame: Two years

No ischemia

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Outcomes of Endovascular Repair of Thoracoabdominal Aortic Aneurysms

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Feb 20, 2024
Registry last updated: Feb 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed